According to the current analysis of Reports and Data, the global Hemophilia B Market was valued at USD 12.41 Billion in 2020 and is expected to reach USD 18.75 Billion by the year 2028, at a CAGR of 5.20%. Hemophilia B is a rare genetic disorder in which blood doesn't clot normally because it lacks sufficient blood-clotting proteins known as clotting factors. Among the types of...